Cargando…

Ovarian cancer: epigenetics, drug resistance, and progression

Ovarian cancer (OC) is one of the most common malignant tumors in women. OC is associated with the activation of oncogenes, the inactivation of tumor suppressor genes, and the activation of abnormal cell signaling pathways. Moreover, epigenetic processes have been found to play an important role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Weiwei, Sun, Huizhen, Li, Xiaoduan, Lin, Feikai, Wang, Ziliang, Wang, Xipeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369623/ https://www.ncbi.nlm.nih.gov/pubmed/34404407 http://dx.doi.org/10.1186/s12935-021-02136-y

Ejemplares similares

Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
por: Lin, Feikai, et al.
Publicado: (2022)

The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis
por: Wang, Xinjing, et al.
Publicado: (2021)

Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2
por: Li, Xiaoduan, et al.
Publicado: (2021)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer
por: Wang, Xinjing, et al.
Publicado: (2021)

Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer
por: Zheng, Xiaocui, et al.
Publicado: (2023)

Development and internal validation of a Nomogram for preoperative prediction of surgical treatment effect on cesarean section diverticulum
por: Wang, Yizhi, et al.
Publicado: (2019)

MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
por: Chen, Xin, et al.
Publicado: (2019)

Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
por: Sun, Huizhen, et al.
Publicado: (2020)

Epigenetic therapy for ovarian cancer: promise and progress
por: Moufarrij, Sara, et al.
Publicado: (2019)

OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway
por: Xie, Weiwei, et al.
Publicado: (2022)

Ovarian cancer, the coagulation pathway, and inflammation
por: Wang, Xipeng, et al.
Publicado: (2005)

Targeting epigenetic regulators to overcome drug resistance in cancers
por: Wang, Nan, et al.
Publicado: (2023)

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
por: Zhang, Xiaoqian, et al.
Publicado: (2023)

Overcome cancer drug resistance by targeting epigenetic modifications of centrosome
por: Jia, Zan-Hui, et al.
Publicado: (2019)

Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Epigenetics in ovarian cancer: premise, properties, and perspectives
por: Yang, Qilian, et al.
Publicado: (2018)

Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance
por: Visco, Zachary R., et al.
Publicado: (2021)

The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression
por: Ciesielski, Oskar, et al.
Publicado: (2020)

Epigenetic Regulation of Antifungal Drug Resistance
por: Patra, Sandip, et al.
Publicado: (2022)

The role of epigenetic modifications in drug resistance and treatment of breast cancer
por: Karami Fath, Mohsen, et al.
Publicado: (2022)

Exploiting epigenetic dependencies in ovarian cancer therapy
por: Coughlan, Aisling Y., et al.
Publicado: (2021)

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
por: Lei, Pan, et al.
Publicado: (2023)

Epigenetic regulation in cancer progression
por: Baxter, Eva, et al.
Publicado: (2014)

Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2011)

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
por: Chen, Siqi, et al.
Publicado: (2022)

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
por: Castilho, Rogerio M., et al.
Publicado: (2017)

Epigenetic basis of cancer drug resistance
por: Aziz, Moammir H., et al.
Publicado: (2020)

Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer
por: Yang, Yufei, et al.
Publicado: (2021)

Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors
por: Zhu, Qinyi, et al.
Publicado: (2017)

The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
por: Wang, Ziliang, et al.
Publicado: (2022)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
por: Wang, Shuang, et al.
Publicado: (2020)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Targeting Nrf2 may reverse the drug resistance in ovarian cancer
por: Li, Danjie, et al.
Publicado: (2021)

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
por: Loret, Nele, et al.
Publicado: (2019)

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
por: Alatise, Kharimat Lora, et al.
Publicado: (2022)

The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression
por: ElShamy, Wael M.
Publicado: (2016)

EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance
por: Tavsan, Zehra, et al.
Publicado: (2020)

Epigenetic Control of Autophagy by MicroRNAs in Ovarian Cancer
por: Titone, Rossella, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0cvpmejohf95b7eqgfufeo944e